Drug industry

182. The Reality of Science: Conflicts of Interest Must Be Addressed

There is an impression that science and scientists are dedicated to conducting independent studies which will provide objective results that can be regarded as definitive. Unfortunately the reality is anything but. Individuals who happen to be working as scientists are subject to all the pressures and prejudices which are common to everyone. Invariably people have […]

182. The Reality of Science: Conflicts of Interest Must Be Addressed Read More »

171. Bad Science

In an ideal world, the various checks and balances that are applied would ensure that information presented in the scientific journals, especially those regarded as prestigious, is sound and reliable. Unfortunately there is convincing evidence that this is not the case. In an article published in the BMJ, Tricia Greenhalgh and colleagues have concluded that

171. Bad Science Read More »

166. HUGE OPPORTUNITY FOR THE NEW GOVERNMENT TO DEVISE A RADICAL HEALTH POLICY (PART 1)

Now that the Conservatives have enough MPs to form a government, they should seize the initiative to tackle some fundamental issues about public health. At the outset it is crucial to question much of the current thinking. It is essential to appreciate that the present strategies are just not working. The incidence of Type 2

166. HUGE OPPORTUNITY FOR THE NEW GOVERNMENT TO DEVISE A RADICAL HEALTH POLICY (PART 1) Read More »

151. Praluent: New Cholesterol Drugs Get Riskier By The Day

This is a re-post of the article by Francois Lubbe of The Cholesterol Truth. I am most grateful to him for permission to post here. The original is available at http://www.thecholesteroltruth.com/praluent-cholesterol-drugs-side-effects-hypercholesterolemia/ Big Pharma seems intent in sticking to its backward way of thinking when it comes to cholesterol. So far their efforts, to create a

151. Praluent: New Cholesterol Drugs Get Riskier By The Day Read More »

137. Corruption of the Scientific Literature: Ghost Writing

Anyone reading a scientific paper in a reputable journal which uses a peer-review system expects the information to be reliable and objective. Unfortunately this is not necessarily the case because there is now convincing evidence that the pharmaceutical industry devotes huge resources to influencing the way in which the material is presented with particular reference

137. Corruption of the Scientific Literature: Ghost Writing Read More »

109. Cochrane Collaboration Evaluates Statins for Primary Prevention of Heart Disease

The Cochrane Collaboration has established a unique reputation for the publication of reports on a variety of topics in the medical field. This is an area where there are very powerful vested interests and the quality of much of the research is questionable. Therefore the contribution of the Collaboration has proved to be extremely valuable

109. Cochrane Collaboration Evaluates Statins for Primary Prevention of Heart Disease Read More »

Scroll to Top